Key Insights

Highlights

Success Rate

85% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

4.9%

2 terminated out of 41 trials

Success Rate

84.6%

-1.9% vs benchmark

Late-Stage Pipeline

5%

2 trials in Phase 3/4

Results Transparency

36%

4 of 11 completed with results

Key Signals

4 with results85% success

Data Visualizations

Phase Distribution

24Total
Not Applicable (6)
P 1 (11)
P 2 (5)
P 3 (2)

Trial Status

Recruiting17
Completed11
Active Not Recruiting6
Not Yet Recruiting4
Terminated2
Enrolling By Invitation1

Trial Success Rate

84.6%

Benchmark: 86.5%

Based on 11 completed trials

Clinical Trials (41)

Showing 20 of 20 trials
NCT05956626Phase 2Active Not RecruitingPrimary

A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease

NCT07161544Phase 1RecruitingPrimary

A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)

NCT07734064Phase 1Not Yet RecruitingPrimary

A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions

NCT07419334Phase 3RecruitingPrimary

Study of ALK-001 on the Progression of Stargardt Disease

NCT07425574RecruitingPrimary

A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults

NCT04545736Phase 1Active Not Recruiting

Oral Metformin for Treatment of ABCA4 Retinopathy

NCT03011541Not ApplicableRecruiting

Stem Cell Ophthalmology Treatment Study II

NCT06591806Active Not RecruitingPrimary

An Observational Study in Children and Adults With Stargardt Disease

NCT07594236Phase 1Recruiting

Phase 1 Study of C.001 in Retinal Degeneration

NCT02435940Recruiting

Inherited Retinal Degenerative Disease Registry

NCT07439887Phase 1RecruitingPrimary

Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease

NCT07266584Not ApplicableRecruitingPrimary

Restoration of Central Vision With PRIMA in Patients With Photoreceptor Degeneration

NCT07502664Recruiting

Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited Retinal Disease (DEFINE-IRD)

NCT06445322RecruitingPrimary

Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)

NCT07417566Phase 1RecruitingPrimary

A Study of DC6001 Tablet in Healthy Chinese Adult Subjects

NCT07298174Not Yet Recruiting

Wide Field OCTA in Ocular Diseases

NCT07265895Not Yet Recruiting

Inherited Retinal Diseases: Natural History and Genotype-Phenotype Correlations

NCT06467344Phase 1RecruitingPrimary

Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)

NCT06319872Phase 1Recruiting

The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration

NCT06435000Recruiting

An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene

Scroll to load more

Research Network

Activity Timeline